SCHEMBL27286217

SCHEMBL27286217

O=C(O)c1ccc(Cl)c(N[SH](=O)=O)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.64
▸ MAPT P10636 1/20 0.64
▸ TSHR P16473 2/20 0.55
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ NPC1 O15118 2/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ CASR P41180 1/20 0.47
▸ HTT P42858 1/20 0.45
▸ LTB4R Q15722 1/20 0.45
▸ SRD5A2 P31213 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ PPARG P37231 1/20 0.43
▸ NR1H4 Q96RI1 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27296313 0.86 MAPT (0.46) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL28623470 0.84 ALDH1A1 (0.49) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL13808926 0.79 ALDH1A1 (0.70) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL14624383 0.79 AKR1C3 (0.50) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL27347830 0.79 HDAC1 (0.44) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL6622364 0.78 ALDH1A1 (1.00) ALDH1A1MAPTTSHRMEN1KMT2A
Hydrochloric Acid SCHEMBL6624955 0.76 ALDH1A1 (0.96) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL24003733 0.75 RAB9A (0.46) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL3335783 0.75 ALDH1A1 (0.69) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL1459456 0.75 ALDH1A1 (0.71) ALDH1A1MAPTTSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100422146-C Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2008-10-01 — — CN claimed
CN-1927833-A Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2007-03-14 — — CN claimed
CN-119751330-A Synthesis method of indapamide intermediate-N-amino-2-methylindoline hydrochloride 天津力生制药股份有限公司 2025-04-04 — — CN disclosed
CN-116041228-B Synthesis method of bumetanide 沈阳希贝康医药科技有限公司 2024-03-12 — — CN disclosed
CN-116219512-A PPA electroplated tail pipe part and production process thereof 宁波四维尔工业有限责任公司 2023-06-06 — — CN disclosed
CN-116041228-A Synthesis method of bumetanide 沈阳希贝康医药科技有限公司 2023-05-02 — — CN disclosed
CN-115724641-A Mildew-proof antibacterial autoclaved aerated building block and preparation method thereof 广州市贤达建材有限公司 2023-03-03 — — CN disclosed
CN-108997176-B 4-chloro-N-substituted phenyl-3-sulfonyl aminobenzamide compound, and preparation and anti-tumor application thereof 温州医科大学 2021-07-02 — — CN disclosed
CN-110538160-A indapamide tablet and preparation method thereof SUICHENG PHARMACEUTICAL CO LTD 2019-12-06 — — CN disclosed
CN-100422146-C Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2008-10-01 — — CN disclosed
CN-100422146-C Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2008-10-01 — — CN disclosed
CN-1927833-A Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2007-03-14 — — CN disclosed
CN-1927833-A Synthesis method of indapamide TIANJIN LISHENG PHARMACEUTICAL (CN) 2007-03-14 — — CN disclosed
CN-1639141-A Novel thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors WARNER LAMBERT CO (US) 2005-07-13 — — CN disclosed
CN-1012642-B Process for preparing sulfamoylbenzoic acid derivatives KYORIN SEIYAKU KK (JP) 1991-05-22 — — CN disclosed
CN-85108940-A The preparation method of sulfamoylbenzoic acid derivatives — 1986-10-22 — — CN disclosed
Send feedback